Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
Clinical trial NCT04352621 · UNKNOWN
Trial details
- NCT number
- NCT04352621
- Sponsor
- University of Cincinnati
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2022-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.